Thematic Issue

Cardiovascular Endocrinology 2020

February 17, 2020

an Endocrine Society Thematic Issue

 

Read our special collection of journal articles, published in 2019–2020, focused on cardiovascular endocrinology! Curation of the collection was guided by Altmetric Attention Scores and Featured Article designations.

Donath and coauthors review the role of inflammation in the pathophysiology of cardiometabolic disease in Endocrine Reviews, and Di Pino and DeFronzo discuss whether the insulin resistance explains the excess cardiovascular risk seen in patients with type 2 diabetes.

Liimatta and colleagues, writing in JES, find no association between premature adrenarche and atherosclerosis or hypertension in adult women, although there was a link to central fat and impaired glucose metabolism. Haywood and colleagues investigate the role of insulin-like growth factor binding protein 1 in mice and find effects on endothelial regeneration and perfusion and angiogenesis.

Torres Fernandez and colleagues, in Endocrinology, find that liraglutide improved dyslipidemia in a rat model of polycystic ovary syndrome and had cardiovascular effects that were likely influenced by hyperandgrogenemia. Asghari and coauthors report strong promotion of adiposity and adipogenic inflammatory signaling in mice by 27-hydroxycholesterol, which also induces inflammatory responses in vascular epithelial cells.

In JCEM, Shen and colleagues find an unexplained inverse association between body mass index and risk of stroke in patients with type 2 diabetes. Cortés and colleagues find an inverse association between sex-hormone-binding globulin and carotid total plaque area in midlife women, with an echogenicity effect of estrone. And Higgins and coauthors find in apparently healthy children and adolescents a marked influence of adiposity on numerous biochemical markers, including elevated triglycerides and apolipoprotein B, which are associated with increased risk of developing cardiovascular disease in adults with type 2 diabetes.

View this collection

Published: February 2020


About Endocrine Society Thematic Issues

It can be difficult to keep up to date in the rapidly evolving and expanding world of endocrine science. We curate topical collections of research from across our journals, Endocrine Reviews, Endocrinology, Journal of the Endocrine Society, and The Journal of Clinical Endocrinology & Metabolism, so that you can easily find and read recent, influential articles on the topics that interest you.

Selection in each Thematic Issue is guided by online metrics, including Altmetric Attention Scores, Featured Article designations, and identification of leading authors and key topics. Each month, we publish a new Thematic Issue online and work to highlight and promote endocrine science in the press, through email, on social media and across other distribution channels.

 
 
 
Last Updated:
Thematic Issues
Membership

Become a Member

Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.

Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.

Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
Publishing Benefits

Author Resource Center

We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.